Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Thanks for posting. Unfortunately, just a summary of what we already knew. Trial design still shows 2400 patients with a 250 event target. No mention of US patients. No mention of changes to the futility analysis. No mention of letter of intent. There did seem to be emphasis on secondary/exploratory BETonMACE endpoints. I was hoping for more but not really expecting anything new here. The silence continues.
